Utilization of Allogeneic Liver Progenitor Cells Expanded from Adult Healthy Human Livers to Treat Genetic Disorders

CellTherapy-PrometheraPromethera Biosciences presents this case study detailing how HHALPC from normal adult livers can be purified, expanded In vitro and utilized to successfully treat patients with Crigler-Najjar disease.
Eric Halioua, Chief Executive Officer, Promethera Biosciences


Listen to the audio cast here

[sc_embed_player_template1 fileurl=”http://commondatastorage.googleapis.com/bpidm/Utilization-of-Allogeneic-Liver-Progenitor-Cells-Expanded-from-Adult-Healthy-Human-Livers-to-Treat-Genetic-Disorders.mp3″]